Literature DB >> 2787098

Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.

L J Bernstein1, M R Bye, A Rubinstein.   

Abstract

Eighteen children with the acquired immunodeficiency syndrome (AIDS) were diagnosed as having Pneumocystis carinii pneumonia (PCP) by either open lung biopsy or bronchoalveolar lavage. Seven patients (39%) died during the acute illness. Alveolar-arterial oxygen gradients at the time of presentation and lactate dehydrogenase levels did not distinguish survivors from nonsurvivors. Total lymphocyte and T4 cell counts were low in children who died during the initial PCP infection but had considerable overlap with survivors. Response to phytohemagglutinin was measured in 5 of the 7 patients who died initially. In these patients, the mean phytohemagglutinin response was 1977 cpm. Of the 11 early survivors, 10 died within 27 months after PCP. Mean phytohemagglutinin response was 46,079 cpm in patients who died within 1 year, and 44,768 cpm in those who died later. Only 1 child is still alive 5 years after PCP illness. Children with AIDS and PCP infection have high initial mortality and poor long-term prognosis. Response to phytohemagglutinin is helpful in predicting who will survive initial PCP infection.

Entities:  

Mesh:

Year:  1989        PMID: 2787098     DOI: 10.1001/archpedi.1989.02150190025013

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  9 in total

Review 1.  Clinical and immunological assessment of HIV infection.

Authors:  A G Bird
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

2.  First experience with pentamidine inhalation in human immunodeficiency virus-infected children.

Authors:  W Kreuz; T Güngör; M Funk; R Linde; S Ehrenforth; C Lotz; B Kornhuber
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

3.  Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia.

Authors:  S C Marriage; H Underhill; S Nadel
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

4.  Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach.

Authors:  U D Allen; S E Read
Journal:  Can J Infect Dis       Date:  1993-11

5.  The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group.

Authors: 
Journal:  J Clin Epidemiol       Date:  1996-11       Impact factor: 6.437

6.  Combined therapy in human immunodeficiency virus-infected children--a 4-year experience.

Authors:  T Güngör; M Funk; R Linde; I Kynast; A Allendorf; C Lotz; S Ehrenforth; D Hofmann; B Kornhuber; W Kreuz
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

Review 7.  Anaesthesia and the child with HIV infection.

Authors:  D Schwartz; T Schwartz; E Cooper; J Pullerits
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

8.  Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles.

Authors:  D M Gibb; C F Davison; F J Holland; S Walters; V Novelli; J Mok
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

9.  CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. European Collaborative Study Group.

Authors: 
Journal:  BMJ       Date:  1994-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.